Harnessing analytical tool innovation for R&D, product characterization, and QC

Nucleic Acid Insights 2026; 3(5), 361–364

DOI: 10.18609/nai.2026.043

Published: 29 June
Foreword
Jeske Smink


“As RNA therapeutics continue their journey from niche technologies to mainstream medicines ... it has become a strategic enabler of innovation, manufacturability and regulatory confidence.